Evaluation of Synergetic Anticancer Activity of Berberine and Curcumin on Different Models of A549, Hep-G2, MCF-7, Jurkat, and K562 Cell Lines

Table 6

Average percent activity of 95% Berberine.

Concentration in mg/mL	Average percent activity of 95% Berberine
	Hep-G2	A549	MCF-7	Jurkat	K562
0.500	85.085	64.878	87.214	85.085	23.130
0.167	45.384	42.561	36.227	37.247	21.188
0.056	19.290	14.390	10.655	−2.023	37.236
0.019	−1.547	32.398	−17.403	−3.372	37.750
0.006	5.816	19.472	−22.336	−20.519	17.533
0.002	4.136	19.797	−33.741	−39.348	5.768